Multidisciplinary Pain Management in Oncology: Balancing Opioid Use and Alternative Therapies
DOI:
https://doi.org/10.12775/QS.2025.40.59242Keywords
cancer pain, opioids, adjuvant therapies, non-pharmacological pain manegement, quality of life, opioid pharmacokinetics, neuropathic pain, multidisciplinary teams, paliative careAbstract
Introduction and purpose:Pain management in cancer patients remains a critical aspect of oncology care, significantly impacting quality of life and treatment outcomes. Despite advancements in cancer therapy, pain continues to be a prevalent and debilitating symptom, affecting up to 80% of patients with advanced cancer. This article aims to synthesize the latest evidence on the role of opioids in cancer pain management, focusing on their efficacy, safety, and factors influencing their use. It also explores the potential of multidisciplinary interventions and the contributions of nursing care in optimizing pain management.
Materials and methods:A literature review was conducted, encompassing clinical trials, meta-analyses, and guidelines on cancer pain management. The review analyzed the mechanisms of cancer pain, opioid classification, pharmacokinetics and pharmacodynamics, as well as alternative pain management strategies, including non-opioid therapies and non-pharmacological interventions.
Results:Opioids remain the cornerstone of cancer pain management, particularly for moderate to severe pain. However, their use is associated with risks such as constipation, nausea, respiratory depression, and potential immunosuppressive effects. Alternative therapies, including adjuvants and non-pharmacological interventions, play a crucial role in managing pain, especially in patients with neuropathic pain. Multidisciplinary team approaches have shown promise in improving pain control and patient QOL.
Conclusion:Effective cancer pain management requires an individualized approach, integrating both pharmacological and non-pharmacological strategies. Further research is needed to optimize opioid use, develop novel therapies, and integrate digital technologies into pain management. Multidisciplinary collaboration and a holistic approach to patient care are essential for improving treatment outcomes.
References
References:
1. Imkamp MSV, Theunissen M, Viechtbauer W, van Kuijk SMJ, van den Beuken — van Everdingen MHJ. Shifting Views on Cancer Pain Management: A Systematic Review and Network Meta-Analysis. J Pain Symptom Manage. 2024;68(3):223-236. doi:10.1016/j.jpainsymman.2024.05.022
2. Chen, D., Chen, D., Sun, H., You, D., Tang, H., Li, S., Song, P., Xu, S., Guo, L., Sun, L., Yang, B., & Liang, J. (2025). Efficacy of multidisciplinary pain management for advanced cancer patients. Pain Management Nursing, xxx(xxx), xxx. https://doi.org/10.1016/j.pmn.2025.01.003
3. Abdel Shaheed, C., Hayes, C., Maher, C. G., Ballantyne, J. C., Underwood, M., McLachlan, A. J., Martin, J. H., Narayan, S. W., & Sidhom, M. A. (2024). Opioid analgesics for nociceptive cancer pain: A comprehensive review. CA: A Cancer Journal for Clinicians, 74(3), 286–313.2023;23(4):337-346. doi:10.3322/caac.21823
4. Rozman de Moraes, A.; Erdogan, E.; Azhar, A.; Reddy, S.K.; Lu, Z.; Geller, J.A.; Graves, D.M.; Kubiak, M.J.; Williams, J.L.; Wu, J.; et al. Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Curr. Oncol. 2024, 31, 1335–1347. https://doi.org/10.3390/curroncol31030101
5. Ripamonti, C. I., & Chelazzi, C. (2024). Total pain, opioids, and immune checkpoint inhibitors in the survival of patients with cancer. ESMO Open, 9(9), 103688. https://doi.org/10.1016/j.esmoop.2024.103688
6. Lee, Y.-C., Brake, T., Zhao, E., Dumitrescu, A., Lee, W., Tassie, B., Khor, K.-E., & Wang, A. Y.-Y. (2024). The use of interventional procedures for cancer pain: A brief review. Supportive Care in Cancer, 32(1), 285. https://doi.org/10.1007/s00520-024-08467-6
7. Vidal Pinheiro, A., Petrucci, G. N., Dourado, A., Silva, F., & Pires, I. (2024). Pain management in animals with oncological disease: Opioids as influencers of immune and tumor cellular balance. Cancers, 16(17), 3015. https://doi.org/10.3390/cancers16173015
8. Mulvey, M. R., Paley, C. A., Schuberth, A., King, N., Page, A., & Neoh, K. (2024). Neuropathic pain in cancer: What are the current guidelines? Current Treatment Options in Oncology, 25(1193–1202). https://doi.org/10.1007/s11864-024-01248-7
9. Aapro, M., Fogli, S., Morlion, B., & Danesi, R. (2024). Opioid metabolism and drug-drug interaction in cancer. The Oncologist, 29, 931–942. https://doi.org/10.1093/oncolo/oyae094
10. Amaram-Davila, J., Franco Vega, M., Kim, M. J., Dalal, S., Dev, R., Tanco, K., Admane, S., De Moraes, A. R., Thomas, L. A., Shelal, Z., Gogineni, M., Bramati, P., Urbauer, D., Hui, D., Arthur, J., Haider, A., Bruera, E., & Reddy, A. (2024). Perceptions toward naloxone among patients with cancer receiving opioids. Journal of Pain and Symptom Management, 68(6), e500–e507. https://doi.org/10.1016/j.jpainsymman.2024.08.034
11. Jones, K. F., White, G., Bennett, A., Bulls, H., Escott, P., Orris, S., Escott, E., Fischer, S., Hamm, M., Krishnamurti, T., Wong, R., LeBlanc, T. W., Liebschutz, J., Meghani, S., Smith, C., Temel, J., Ritchie, C., & Merlin, J. S. (2024). Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study. JMIR Research Protocols, 13, e54953. https://doi.org/10.2196/54953
12. Ye, L., Li, Y.-H., Huang, Y.-H., Deng, Q. C., Huang, Y.-X., Peng, Y.-H., & Li, D. (2024). Effectiveness of non-pharmacological interventions for pain management in patients with cancer: a protocol for systematic review and network meta-analysis. BMJ Open, 14, e084500. https://doi.org/10.1136/bmjopen-2024-084500
13. Secondulfo, C., Mazzeo, F., Pastorino, G. M. G., Vicidomini, A., Meccariello, R., & Operto, F. F. (2024). Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness. International Journal of Molecular Sciences, 25(17), 9407. https://doi.org/10.3390/ijms25179407
14. Bimonte, S., Nocerino, D., Schiavo, D., Crisci, M., Cascella, M., & Cuomo, A. (2024). Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives. Anticancer Research, 44(2), 895-900. https://doi.org/10.21873/anticanres.16883
15. Azari, L., Hemati, H., Tavasolian, R., Shahdab, S., Tomlinson, S. M., Bobonis Babilonia, M., Huang, J., Tometich, D. B., Turner, K., Jim, H. S. L., & Tabriz, A. A. (2024). The Efficacy of Ketamine for Acute and Chronic Pain in Patients with Cancer: A Systematic Review of Randomized Controlled Trials. Healthcare, 12(12), 1560. https://doi.org/10.3390/ healthcare12161560
16. Bhuyan, S., Bhuyan, D., & Rahane, S. (2024). Optimizing Regional Anesthesia for Cancer Patients: A Comprehensive Review of Current Practices and Future Directions. Cureus, 16(9), e69315. https://doi.org/10.7759/cureus.69315
17. Wiffen, P. J., Wee, B., Derry, S., Bell, R. F., & Moore, R. A. (2017). Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews, 2017(7), CD012592. https://doi.org/10.1002/14651858.CD012592.pub2
18. Sah, D., Shoffel-Havakuk, H., Tsur, N., Uhelski, M. L., Gottumukkala, V., & Cata, J. P. (2024). Opioids and Cancer: Current Understanding and Clinical Considerations. Current Oncology, 31(6), 3086–3098. https://doi.org/10.3390/curroncol31060235
19. Mystakidou, K., Tsilika, E., Tsiatas, M., & Vlahos, L. (2007). Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. International Journal of Nanomedicine, 2(1), 49–54. DOI: 10.2147/nano.2007.2.1.49
20. Kistemaker, K. R. J., Sijani, F., Brinkman, D. J., de Graeff, A., Burchell, G. L., Steegers, M. A. H., & van Zuylen, L. (2024). Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis. Cancer Treatment Reviews, 125, 102704. https://doi.org/10.1016/j.ctrv.2024.102704
21. Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., Novick, K. L. M., Sedhom, R., Seigel, C., Stimmel, J., & Bruera, E. (2022). Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. Journal of Clinical Oncology, 41(4), 914-930. https://doi.org/10.1200/JCO.22.02198
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Wiktoria Tabin-Barczak, Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 41
Number of citations: 0
